PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-205 Cr |
| Mar2024 | ₹-235 Cr |
| Mar2023 | ₹-346 Cr |
| Mar2022 | ₹-181 Cr |
| Mar2021 | ₹-1,571 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-205 Cr | Negative | |
| Mar2024 | ₹-235 Cr | Negative | |
| Mar2023 | ₹-346 Cr | Negative | |
| Mar2022 | ₹-181 Cr | Negative | |
| Mar2021 | ₹-1,571 Cr | - | |
Compare Cash Flow from Financing Activities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹21,135.6 Cr | -0.7% | -3.5% | -9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -0.7% |
-3.5% |
-9.4% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses